Polysaccharide superparamagnetic iron oxide contrast agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Polysaccharide superparamagnetic iron oxide contrast agent, covering 2023-09-29 to 2023-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients [Phase 1, Phase 2]